Your browser doesn't support javascript.
loading
Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy.
Tannock, I F; Bouche, G; Goldstein, D A; Goto, Y; Lichter, A S; Prabhash, K; Ranganathan, P; Saltz, L B; Sonke, G S; Strohbehn, G W; von Moos, R; Ratain, M J.
Afiliação
  • Tannock IF; Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada; Optimal Cancer Care Alliance, Ann Arbor, USA. Electronic address: ian.tannock@uhn.ca.
  • Bouche G; Anticancer Fund, Meise, Belgium; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Goldstein DA; Optimal Cancer Care Alliance, Ann Arbor, USA; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Lichter AS; Optimal Cancer Care Alliance, Ann Arbor, USA.
  • Prabhash K; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Ranganathan P; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Saltz LB; Optimal Cancer Care Alliance, Ann Arbor, USA; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Sonke GS; Department of Medical Oncology, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands; University of Amsterdam, Amsterdam, The Netherlands.
  • Strohbehn GW; Optimal Cancer Care Alliance, Ann Arbor, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, USA; Section of Hematology Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, USA; Veterans Affairs Center for Clinical Management Research, Ann Arbor, USA.
  • von Moos R; Department of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland; SAKK Competence Center, Bern, Switzerland.
  • Ratain MJ; Optimal Cancer Care Alliance, Ann Arbor, USA; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, USA.
Ann Oncol ; 34(8): 638-644, 2023 08.
Article em En | MEDLINE | ID: mdl-37230253
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article